Explore PLCO
Access to PLCO Data and Biospecimens
- Begin a Data-Only Project
- Begin an Images Project
- Begin an EEMS Biospecimens Application
- Begin a Request Form for Specimen Verification (PAR-21-330)
(More)
Latest PLCO News
Browse Lab Results > 2010-0211
Trial Summary
About CDAS Project, PI, Publications: Inflammation markers and risk of endometrial and ovarian cancer
Datasets
2010-0211 Endometrial
Site: Endometrial
Inclusion Criteria:
- Females in Intervention Arm
- No Rare Cancers
- No Prior History of Any Cancer
- No Confirmed or Reported Cancers in Controls
- No Hysterectomy
- No Endometrial Cancers that are 2nd, reported, or unconfirmable
- Has Any Serum Available
- Has Pre-dx Serum Available
- Frequency Matched at a 1-1 Ratio
Matching Factors:
- Fiscal Year of Randomization
- Age at Randomization (5 year intervals)
- Race (White/Non-White)
- Study Year of Blood Draw
- Study Year of Exit
Match Ratio: 1 to 1
Match Technique: Frequency matching only non-cases as controls.
Analytes:
- Adiponectin
- Adipsin
- B-Cell Attracting Chemokine 1
- Basic Fibroblast Growth Factor
- C-Reactive Protein
- Chemokine (C-C Motif) Ligand 13
- Chemokine (C-C Motif) Ligand 19
- Chemokine (C-C Motif) Ligand 2
- Chemokine (C-C Motif) Ligand 20
- Chemokine (C-C Motif) Ligand 21
- Chemokine (C-C Motif) Ligand 22
- Chemokine (C-C Motif) Ligand 27
- Chemokine (C-C Motif) Ligand 8
- Chemokine (C-X-C Motif) Ligand 1
- Chemokine (C-X-C Motif) Ligand 10
- Chemokine (C-X-C Motif) Ligand 11
- Chemokine (C-X-C Motif) Ligand 12
- Chemokine (C-X-C Motif) Ligand 5
- Chemokine (C-X-C Motif) Ligand 6
- Chemokine (C-X-C Motif) Ligand 9
- Eotaxin
- Eotaxin-2
- Epidermal Growth Factor
- Estradiol
- Granulocyte-Colony Stimulating Factor
- Interleukin 1
- Interleukin 1 Receptor Antagonist
- Interleukin 16
- Interleukin 29
- Interleukin 33
- Interleukin 7
- Interleukin 8
- Lipocalin-2
- Macrophage Inflammatory Protein 1 delta
- Macrophage inflammatory protein 1 beta
- Plasminogen activator inhibitor-1
- Resistin
- Serum Amyloid A
- Serum Amyloid P
- Soluble Epidermal Growth Factor Receptor
- Soluble Interleukin 4 Receptor
- Soluble Interleukin 6 Receptor
- Soluble Interleukin 6 beta
- Soluble Tumor Necrosis Factor Receptor I
- Soluble Tumor Necrosis Factor Receptor II
- Stem Cell Factor
- Thrombopoietin
- Thymic Stromal Lymphopoietin
- Thymus and Activation Regulated Chemokine
- Transforming Growth Factor Alpha
- Transforming Growth Factor Beta 1
- Tumor Necrosis Factor Alpha 1
- Tumor Necrosis Factor Beta
- Tumor Necrosis Factor Receptor Superfamily, Member 10
- Vascular Endothelial Growth Factor
- Vascular endothelial growth factor receptor 2
- Vascular endothelial growth factor receptor 3
Number of Cases: 284
Number of Controls: 284
2010-0211 Ovarian
Site: Ovary
Inclusion Criteria:
- Females in Intervention Arm
- No Rare Cancers in Controls
- No Controls with Oophorectomies
- 2+ Years Pre-Diagnostic Specimen Available
Matching Factors:
- Age at Randomization (5 year intervals)
- Race
- Study Year of Blood Draw
- Year of Blood Draw
- Season of Blood Draw
- Time of Blood Draw (am/pm)
Match Ratio: 1 to 1
Match Technique: Case cohort with controls matched to cases.
Additional Matching Comments: One cell had no matched controls; the case was kept.
Analytes:
- Amylin
- Basic Fibroblast Growth Factor
- C-Peptide
- C-Reactive Protein
- Chemokine (C-C Motif) Ligand 2
- Chemokine (C-C Motif) Ligand 22
- Chemokine (C-X-C Motif) Ligand 1
- Chemokine (C-X-C Motif) Ligand 10
- Chemokine (C-X3-C Motif) Ligand 1
- Chemokine Ligand 7
- Eotaxin
- Epidermal Growth Factor
- Fms-related tyrosine kinase 3 ligand
- Gastric inhibitory polypeptide
- Glucagon
- Glucagon-like peptide-1
- Granulocyte-Colony Stimulating Factor
- Granulocyte-Macrophage Colony Stimulating Factor
- Insulin
- Interferon alpha-2
- Interferon-gamma
- Interleukin 1
- Interleukin 1 Receptor Antagonist
- Interleukin 1 alpha
- Interleukin 1 beta
- Interleukin 10
- Interleukin 12 p40
- Interleukin 12 p70
- Interleukin 15
- Interleukin 17
- Interleukin 2
- Interleukin 3
- Interleukin 4
- Interleukin 5
- Interleukin 6
- Interleukin 7
- Interleukin 8
- Leptin
- Macrophage Inflammatory Protein 1 alpha
- Macrophage inflammatory protein 1 beta
- Pancreatic Polipeptide
- Pancreatic Polipeptide YY
- Soluble Epidermal Growth Factor Receptor
- Soluble Interleukin 1 Receptor Type 1
- Soluble Interleukin 2 Receptor Alpha
- Soluble Interleukin 4 Receptor
- Soluble Interleukin 6 Receptor
- Soluble Interleukin 6 beta
- Soluble Receptor for Advanced Glycation Endproducts
- Soluble Tumor Necrosis Factor Receptor I
- Soluble Tumor Necrosis Factor Receptor II
- Transforming Growth Factor Alpha
- Tumor Necrosis Factor Alpha 1
- Tumor Necrosis Factor Beta
- Tumor Necrosis Factor Receptor Superfamily, Member 5
- Tumor Necrosis Factor Receptor Superfamily, Member 8
- Vascular Endothelial Growth Factor
- Vascular endothelial growth factor receptor 1
- Vascular endothelial growth factor receptor 2
- Vascular endothelial growth factor receptor 3
Number of Cases: 150
Number of Controls: 169
The following datasets contain the data available for 2010-0211. The description and documentation for each file is listed below. SAS7bdat and CSV versions of the actual data will be available to CDAS projects approved to use this data.
Datasets
| Files | Description |
|---|---|
|
Data Dictionary
(PDF - 314.5 KB) |
1. The 2010-0211 Endometrial dataset contains results from 284 cases and 284 controls. |
|
Data Dictionary
(PDF - 323.3 KB) |
2. The 2010-0211 Ovarian dataset contains results from 150 cases and 169 controls. |